Ovid Therapeutics Inc. Accumulated Other Comprehensive Income
Ovid Therapeutics Inc. (OVID) had Accumulated Other Comprehensive Income of -$750.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$750.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$422.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$202.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$126.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$750.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$422.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | -$202.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$126.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$69.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$47.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$35.00K 10-K · filed 2026-03-18 | |
| 2024-09-30 | $36.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$12.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$19.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.00K 10-K · filed 2025-03-11 | $702.00 10-K · filed 2024-03-08 |
| 2023-09-30 | -$3.88K 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $5.21K 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $5.63K 10-Q · filed 2023-05-05 | |
| 2022-12-31 | -$42.19K 10-K · filed 2024-03-08 | |
| 2022-09-30 | -$82.79K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | -$90.13K 10-Q · filed 2022-08-09 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 | |
| 2020-03-31 | $65.70K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.47K 10-K · filed 2021-03-15 | |
| 2019-03-31 | $1.35K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | -$1.83K 10-K · filed 2020-03-11 | |
| 2018-09-30 | -$4.67K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | -$16.02K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$35.91K 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |